Skip to main content
. 2015 Sep 30;2015:434389. doi: 10.1155/2015/434389

Table 1.

Traditional and potential therapies for osteoporosis.

Molecular target Mechanism of action Approved agent
Prenylation Osteolysis inhibitor Zoledronic acid and other bisphosphonates
RANK/RANKL/OPG axis Osteoclastogenesis inhibitor Denosumab
Recombinant osteoprotegerin (OPG) Osteoclastogenesis inhibitor
STA-21 (STAT-3 inhibitor) Osteoclastogenesis inhibitor
TGF-beta Osteoclastogenesis inhibitor
Alpha2/Beta1 integrin Bone homing and drug vehicles